Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

SideChannel Inc. (SDCH) Strengthens Your Organization’s Security Posture with its vCISO Service and the Application of Enclave and RealCISO Technology

SideChannel (OTCQB: SDCH) believes that all companies should be able to easily, and affordably, understand and manage cyber risk. It also believes that a secure network begins with segmentation, the breaking down of complex tasks into easy-to-understand steps, enhancing productivity and reducing risk. This approach is made possible by the offering of SideChannel’s vCISOs, and […]

Sharing Services Global Corp. (SHRG) Dedicated to Developing Opportunities in Growing Direct-Selling Space

In a market forecast to see almost $80 billion growth (https://ibn.fm/7ZJfu), Sharing Services Global (OTCQB: SHRG) is working to offer a variety of options for its brand partners, subscribers and independent sales force. SHRG operates in the direct-selling space, where it is dedicated to developing or acquiring businesses, products and technologies that augment its product […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expecting Additional Growth in 2023, Including IND Filing and IND Clinical Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has released its new corporate presentation (https://ir.lexariabioscience.com/presentations). The presentation augments the positive outlook for the coming year put forth in an earlier released shareholder update letter from the company’s CEO, Chris Bunka. Bunka starts the letter with, “As 2022 came to a close, it […]

Nemaura Medical, Inc. (NASDAQ: NMRD) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference

Nemaura Medical (NASDAQ: NMRD) is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT(R), a CE mark approved Class IIb medical device, is a non-invasive and flexible continuous glucose monitor (“CGM”) providing actionable insights derived from real time glucose measurements and daily glucose trend data, […]

REZYFi, Inc. Provides the Cannabis Industry with Critical Financing Options and Services Still Not Available with Traditional Banking Institutions

In recent years, the cannabis industry has seen significant changes – with 39 states legalizing cannabis for medicinal use and 21 states allowing recreational use. For 2023, the combined sales are projected to reach $38.8 billion for the industry (https://ibn.fm/dqo2m). In spite of this significant growth, there is a challenge that cannabis businesses face – […]

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Commissions Demonstration Plant; Plans for Louisiana Strategic Metals Complex

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a company focused on Rare Earth Element (“REE”) resource development and precious metal commercialization, recently provided an update on the commissioning process for its RapidSX(TM) Demonstration Plant for the separation of heavy and light REEs. The demonstration plant is located within Ucore’s 5000 square foot RapidSX(TM) Commercialization and […]

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Encouraged by Nanosized Antibody Study Results as Market Forecasts Predict Rapid Growth

Immunotherapeutic product innovator BiondVax Pharmaceuticals (NASDAQ: BVXV) is focused on developing, manufacturing, and commercializing innovative nanosized antibodies (NanoAbs) for the treatment of infectious diseases and autoimmune diseases, stepping up its pursuit of disrupting the monoclonal antibody (“mAb”) market amid forecasts that the global mAb market will grow at a compound annual rate (“CAGR”) of 11.30 […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) – Technology Behind Patented Disruptive DehydraTECH(TM) Drug Delivery Platform

Speaking during a late 2022 interview (https://ibn.fm/cWQJX), Chris Bunka, the Chairman and CEO of Lexaria Bioscience (NASDAQ: LEXX), emphasized the varied applications of DehydraTECH(TM), and that, for example, the company intends to help people quit smoking by enabling them to satisfy their nicotine cravings in a way that will not kill them: pouches. This comes […]

 

From Our Blog

Beeline Holdings Inc. (NASDAQ: BLNE) Reaches Cash-Flow Milestone as Growth Strategy Gains Traction

November 21, 2025

Beeline Holdings (NASDAQ: BLNE),  a fast-growing digital mortgage platform redefining the path to homeownership, entered November with a key milestone behind it: its lending entity generated cash-flow positivity in October, a development that the company says reflects improving efficiency and rising adoption of its digital mortgage platform. The achievement, disclosed in a corporate update on […]

Rotate your device 90° to view site.